Recently, full data from the Phase II IDeate-Lung01 study on the antibody-drug conjugate I-DXd in previously treated extensive-stage small-cell lung cancer (ES-SCLC) were publish...

On July 28, 2025 — World Hepatitis Day — Bangladesh-based Beacon Pharmaceuticals officially introduced Sofosvel, the world’s first generic version of Epclusa (SOF/VEL). This mil...

Pharmacil is a key pharmaceutical company under the Radiant Group in Bangladesh. Established in 2005 and headquartered in Dhaka, Bangladesh, it boasts modern pharmaceutical prod...

The Global Cancer Landscape: From First- to Third-Generation Targeted Drugs — How Medicine Is Changing the Fate of CancerNot long ago, a cancer diagnosis was almost a death senten...

Breast cancer remains the most commonly diagnosed cancer among women worldwide. Although its发病 trends and risk factors have been extensively studied, public understanding of how ...

 In the long battle against cancer, human beings have moved from chemotherapy and radiation to targeted drugs, and now to cell-based therapies.Among these innovations, CAR-T cell ...

Many people have heard that a generic drug is considered reliable only if it has passed “BE certification.” But what does BE actually mean? And why is it so important for generic...

Global Diabetes Situation: Over 1 in 10 Adults Affected, Prevention Is More Urgent Than EverDiabetes has long ceased being a disease confined to affluent nations—it has evolved in...

Obesity has become a major global public health challenge. According to the World Obesity Federation, approximately 3 billion people worldwide were overweight or obese by 2024. Exc...

The U.S. Food and Drug Administration (FDA) has officially approved Novartis’ latest gene replacement therapy, Itvisma, marking a significant milestone in the treatment landscape ...